Pharmaceutical Contract Research Organization Industry — Sector Outlook & Stocks

The Pharmaceutical Contract Research Organization industry on FinBizNet covers 1 listed company, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.

Pharmaceutical Contract Research Organization industry at a glance

Listed companies1
Combined market cap₹11,186 Cr
Median P/E (profitable companies)63.5
Median return on equity11.6%
Companies with latest quarterly results1 of 1

Companies in the Pharmaceutical Contract Research Organization industry

CompanyMarket CapP/EROEQuarterly RevenueQuarterly Net ProfitQuarter
Sequent Scientific Ltd₹11,186 Cr63.511.6%₹988 Cr₹85 CrQ2 FY27

Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).

Frequently Asked Questions

Which stocks are in the Pharmaceutical Contract Research Organization industry?

FinBizNet tracks 1 listed company in the Pharmaceutical Contract Research Organization industry: Sequent Scientific Ltd.

What are the largest Pharmaceutical Contract Research Organization companies by market capitalisation?

By market capitalisation, the largest Pharmaceutical Contract Research Organization companies are Sequent Scientific Ltd (₹11,186 Cr).

What is the combined market capitalisation of the Pharmaceutical Contract Research Organization industry?

The 1 Pharmaceutical Contract Research Organization companies tracked on FinBizNet have a combined market capitalisation of about ₹11,186 Cr.

What is the median P/E ratio in the Pharmaceutical Contract Research Organization industry?

The median price-to-earnings ratio across 1 profitable Pharmaceutical Contract Research Organization companies is 63.5, and the median return on equity across the industry is 11.6%. Medians are shown for context only.

What does FinBizNet cover for the Pharmaceutical Contract Research Organization industry?

FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceutical Contract Research Organization industry.